From: Antibiotics for the treatment of Cholera, Shigella and Cryptosporidiumin children
Quality Assessment | Summary of Findings | |||||||
---|---|---|---|---|---|---|---|---|
Ìý | Directness | No of events | Ìý | |||||
No of studies | Design | Limitations | Consistency | Generalizability to population of interest | Generalizability to intervention of interest | Intervention | Control | Relative Risk (95%CI) |
Mortality – All Cause (Antibiotics vs. Placebo): Low Outcome Quality | ||||||||
RCT | One study used nitazoxanide while one used spiramycin | All studies suggested benefit | All studies were conducted in developing country | Hospital based | 1 | 6 | 0.24 [0.04, 1.45] a | |
Clinical Failure (Antibiotics vs. Placebo): Moderate Outcome Quality | ||||||||
RCT | Ìý | Both used nitazoxanide and suggested benefit | All studies were conducted in developing country | Hospital based | 14 | 32 | 0.48 (0.30, 0.75) a | |
Parasitological Failure (Antibiotics vs. Placebo): Moderate Outcome Quality | ||||||||
RCT | Two studies used nitazoxanide While one used spiramycin | All studies suggest benefit | All studies were conducted in developing country | Hospital based | 31 | 51 | 0.62 [0.46, 0.83] a |